Hb limit of 12 g/dL; ESAs should be carefully reconsidered in patients with a high risk of thromboembolic events, used with caution in liver disease, and not given to patients with ESA hypersensitivity or poorly controlled hypertension. This evidence concerns the gene GSTM1 and Hypertension.